Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | IM / RA |
Patient was admitted to the hospital 10/08/21 because after playing soccer he developed dizziness and left-sided weakness . On admission head CT showed large right MCA and small right ACA ischemic CVA with cytotoxic right basal ganglia edema . Head and neck CTA showed occlusion of right ICA at the level of ophthalmic artery. The patient was transferred to another hospital where he had thrombectomy. Additional study was done TEE with did not reveal any shunt, did not reveal any valvular abnormalities. Patient was consulted by neurologist with recommendation treat patient with aspirin, Plavix and statin Because of patient weakness, left-sided neglect, impaired mobility, ADLs he was consulted by PM&R service and decided he will benefit from comprehensive inpatient rehab program and on 10/24/2021 transfer to rehab hospital to start comprehensive inpatient rehab program. Hospital Course: Principal Problem: Ischemic stroke (HCC) -recommended continue aspirin and Plavix Ischemic CVA-EKG showed sinus rhythm but does not explain patient's stroke and cardiology recommended loop recorder after patient will be discharged what could be placed as outpatient Cognitive deficit-patient still require minimal assistance for memory, moderate assistance for problem solving and recommended continue speech therapy as outpatient Impaired balance with left hemiparesis-recommend continue AFO and standard cane for ambulation. This is permanent left hemiparesis as of 2025.
see above